{"id":608,"date":"2020-05-19T10:57:51","date_gmt":"2020-05-19T10:57:51","guid":{"rendered":"http:\/\/www.farmacovigilanciacanarias.org\/noticias\/?p=608"},"modified":"2020-05-19T10:57:51","modified_gmt":"2020-05-19T10:57:51","slug":"nota-informativa-muh-fv-9-2020","status":"publish","type":"post","link":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/2020\/05\/19\/nota-informativa-muh-fv-9-2020\/","title":{"rendered":"Nota Informativa MUH (FV), 9\/2020"},"content":{"rendered":"<table class=\"portada\" border=\"0\">\n<tbody>\n<tr>\n<td><a href=\"https:\/\/www.aemps.gob.es\/informa\/notasinformativas\/medicamentosusohumano-3\/seguridad-1\/2020-seguridad-1\/errores-en-la-reconstitucion-y-administracion-de-los-medicamentos-con-leuprorelina-de-liberacion-prolongada-en-el-tratamiento-del-cancer-de-prostata\/\">Errores en la reconstituci\u00f3n y administraci\u00f3n de los medicamentos con leuprorelina de liberaci\u00f3n prolongada en el tratamiento del c\u00e1ncer de pr\u00f3stata<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Errores en la reconstituci\u00f3n y administraci\u00f3n de los medicamentos con leuprorelina de liberaci\u00f3n prolongada en el tratamiento del c\u00e1ncer de pr\u00f3stata<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-608","post","type-post","status-publish","format-standard","hentry","category-seguridad"],"_links":{"self":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/608","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/comments?post=608"}],"version-history":[{"count":1,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/608\/revisions"}],"predecessor-version":[{"id":609,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/608\/revisions\/609"}],"wp:attachment":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/media?parent=608"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/categories?post=608"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/tags?post=608"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}